ORL Kids Toothpaste Recalled Due to Cross Contamination
Key Takeaways:
- The US Food and Drug Administration (FDA) has issued a voluntary Class II recall for ORL organic oral care cinnamint, bubblegum, and fresh mint kids' natural toothpaste, 4 oz, affecting 30 425 units.
- The recall was initiated by ORL Labs, LLC due to cross contamination, a quality issue that is likely to cause temporary or medically reversible adverse health consequences or has a low probability of serious adverse health consequences.
- Toothpaste is used to clean and strengthen teeth.
The FDA has issued a Class II recall for ORL organic oral care cinnamint, bubblegum, and fresh mint kids' natural toothpaste, 4 oz, affecting 30 425 units. This product is being recalled by ORL Labs, LLC based in Scottsdale, Arizona. The recall was initiated on October 12, 2026, and received a Class II classification on November 6, 2026. A Class II classification means the use of this product is likely to cause temporary or medically reversible adverse health consequences or has a low probability of serious adverse health consequences.
The recall was initiated after the firm discovered cross contamination with progesterone, estradiol, or dehydroepiandrosterone (DHEA). This issue affects Lots 241209P3, 250129P3, 250508P3, 25112P3, and 260511P3 (cinnamint); Lots 241029P4, 250414P4, 250520P4, 260406P4, and 260511P4 (bubblegum); and Lots 250121P7, 250505P7, 250508P7, 250516P7, 250707P7, 251105P7, 260126P7, 260309P7, 260422P7, 260618P7, and 260804P7 (fresh mint) of any expiration date between September 2026 and August 2028. ORL Labs sent out a public notice via letter; no press release has been issued for this recall.
Toothpaste is used to promote dental hygiene by cleaning and strengthening teeth. Pharmacists should identify and quarantine the affected Lots, remove them from inventory, and coordinate with prescribers to provide an alternative supply.
References
- FDA. Enforcement Report. November 18, 2026. Accessed November 18, 2026. https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=223401
- FDA. Enforcement Report. November 18, 2026. Accessed November 18, 2026. https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=223400
- FDA. Enforcement Report. November 18, 2026. Accessed November 18, 2026. https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=223402


